1-10 of 10
Kathleen F. Villa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Post-Hematopoietic Cell Transplant (HCT) Survival on Cost-Effectiveness of CPX-351 Versus 7+3 in the Treatment of Therapy-Related AML or AML-MRC in the United States

Anuraag Kansal, PhD, Odette Reifsnider, Lora Todorova, Anna Coughlan, Kathleen F. Villa
Journal: Blood
Blood (2018) 132 (Supplement 1): 5837.
https://doi.org/10.1182/blood-2018-99-112252
Published: 2018
Journal Articles

Cost-Effectiveness of Defibrotide for the Treatment of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) with Multi-Organ Dysfunction (MOD) Post-Hematopoietic Stem Cell Transplantation (HSCT) in Canada

Jonathan Belsey, Eric Ngonga Kemadjou, Maya Isaila, Kathleen F. Villa
Journal: Blood
Blood (2018) 132 (Supplement 1): 4702.
https://doi.org/10.1182/blood-2018-99-111396
Published: 2018
Journal Articles

Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) with or without Multi-Organ Dysfunction (MOD) after Hematopoietic Stem Cell Transplantation (HSCT): Analysis of a Multicenter Chart Review

Tina Doede, MS, MBA, Anusha Viddam, Kathleen F. Villa, MS, Alison L. Hannah, MD, Charles H. Weaver, MD, William Tappe, MD
Journal: Blood
Blood (2016) 128 (22): 5756.
https://doi.org/10.1182/blood.V128.22.5756.5756
Published: 2016
Journal Articles

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Christopher Strouse, MD, Ying Zhang, Mei-Jie Zhang, PhD, Alyssa DiGilio, MS, Marcelo C. Pasquini, MD, Mary M. Horowitz, MD MS, Stephanie J. Lee, MD, Muthalagu Ramanathan, MD, Wichai Chinratanalab, MD, Alison W Loren, MD MS, Linda J. Burns, MD, Andrew Artz, MD, Kathleen F. Villa, MS, Wael Saber, MD MS
Journal: Blood
Blood (2016) 128 (22): 983.
https://doi.org/10.1182/blood.V128.22.983.983
Published: 2016
Journal Articles

Hospital Cost Associated with Veno-Occlusive Disease (VOD) in Patients with Hematopoietic Stem Cell Transplant (HSCT)

Christopher C. Dvorak, MD, Bijan Nejadnik, MD, Zhun Cao, PhD, Craig Lipkin, MS, Scott B. Robinson, MA, MPH, Kathleen F. Villa, MS
Journal: Blood
Blood (2015) 126 (23): 4452.
https://doi.org/10.1182/blood.V126.23.4452.4452
Published: 2015
Journal Articles

Costs of Hematopoietic Stem Cell Transplantation and Associated Conditioning Regimens

Tiffany P. Quock, PhD MS, Michael S. Broder, MD MSHS, Eunice Chang, PhD, Sheila R. Reddy, PhD MS, RPh, Sally Arai, MD, Rajni Agarwal-Hashmi, MD, Kathleen F. Villa, MS
Journal: Blood
Blood (2015) 126 (23): 3270.
https://doi.org/10.1182/blood.V126.23.3270.3270
Published: 2015
Journal Articles

A Model Estimating Indirect Costs of Premature Death Associated with Severe Hepatic Veno-Occlusive Disease (sVOD) Among Hematopoietic Stem Cell Transplant (HSCT) Patients in the United States (U.S.)

Tiffany P. Quock, PhD MS, Zheng-Yi Zhou, PhD, Byran Dai, MS, Wenxi Tang, MS, Kathleen F. Villa, MS
Journal: Blood
Blood (2015) 126 (23): 3273.
https://doi.org/10.1182/blood.V126.23.3273.3273
Published: 2015
Journal Articles

Incidence of Hepatic Veno-Occlusive Disease (VOD) in Premier Healthcare Database

Christopher C. Dvorak, MD, Bijan Nejadnik, MD, Zhun Cao, PhD, Craig Lipkin, MS, Scott B. Robinson, MA, MPH, Kathleen F. Villa, MS
Journal: Blood
Blood (2015) 126 (23): 3280.
https://doi.org/10.1182/blood.V126.23.3280.3280
Published: 2015
Journal Articles

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival

Paul G. Richardson, Nancy A. Kernan, MD, Stephan A. Grupp, MD PhD, Paul L. Martin, MD PhD, Robert J. Soiffer, MD, Richard Martin, MBChB, B(MDSc, MRCGP, Alison L. Hannah, MD, Kathleen F. Villa, MS
Journal: Blood
Blood (2014) 124 (21): 2469.
https://doi.org/10.1182/blood.V124.21.2469.2469
Published: 2014
Journal Articles

Risk-Benefit Trade-Off of Pediatric-Inspired Versus Hyper-CVAD Protocols for Philadelphia Negative Acute Lymphocytic Leukemia (ALL) in Adolescents and Young Adults: A Modeling Analysis

Gregory F. Guzauskas, MSPH, PhD, Kathleen F. Villa, MS, Trudy F. Vanhove, MD PhD MBA, David L. Veenstra, PharmD, PhD
Journal: Blood
Blood (2014) 124 (21): 1281.
https://doi.org/10.1182/blood.V124.21.1281.1281
Published: 2014